Prominent Doctors Aren’t Disclosing Industry Ties in Publications
- Total Posts: 3,226
One is dean of Yale’s medical school. Another is the director of a cancer center in Texas. A third is the next president of the most prominent society of cancer doctors.
These leading medical figures are among dozens of doctors who have failed in recent years to report their financial relationships with pharmaceutical and health care companies when their studies are published in medical journals, according to a review by ProPublica and The New York Times and data from other recent research.
Dr. Howard A. “Skip” Burris III, the president-elect of the American Society of Clinical Oncology, for instance, declared that he had no conflicts of interest in more than 50 journal articles in recent years, including in the prestigious New England Journal of Medicine.
However, drug companies have paid his employer nearly $114,000 for consulting and speaking, and nearly $8 million for his research during the period for which disclosure was required. His omissions extended to the Journal of Clinical Oncology, which is published by the group he will lead.
Of course they not disclosing there ties to industry, it will blow their credibility.
The Media is the biggest blame for this. News on the cheap does not do their homework.
If you cannot dazzle them with brilliance, baffle them with bullshit WC FieldsWarning DO NOT CLICK HERE!
December 20, 2018 at 3:53 AM #2723Cold Mountain TrailParticipant
- Total Posts: 12,931
their ties: they don’t publish when the results aren’t what’s expected (which skews perception), the research topics are slanted to ones that will produce dollar results, there’s little support for non-monetizable research, etc etc etc
December 20, 2018 at 10:59 AM #2794
- You must be logged in to reply to this topic.